Osteopontin is Indispensible for AP1-mediated Angiotensin II-related MiR-21 Transcription During Cardiac Fibrosis
Overview
Authors
Affiliations
Aims: Osteopontin (OPN) is a multifunctional cytokine critically involved in cardiac fibrosis. However, the underlying mechanisms are unresolved. Non-coding RNAs are powerful regulators of gene expression and thus might mediate this process.
Methods And Results: OPN and miR-21 were significantly increased in cardiac biopsies of patients with myocardial fibrosis. Ang II infusion via osmotic minipumps led to specific miRNA regulations with miR-21 being strongly induced in wild-type (WT) but not OPN knockout (KO) mice. This was associated with enhanced cardiac collagen content, myofibroblast activation, ERK-MAP kinase as well as AKT signalling pathway activation and a reduced expression of Phosphatase and Tensin Homologue (PTEN) as well as SMAD7 in WT but not OPN KO mice. In contrast, cardiotropic AAV9-mediated overexpression of OPN in vivo further enhanced cardiac fibrosis. In vitro, Ang II induced expression of miR-21 in WT cardiac fibroblasts, while miR-21 levels were unchanged in OPN KO fibroblasts. As pri-miR-21 was also increased by Ang II, we studied potential involved upstream regulators; Electrophoretic Mobility Shift and Chromatin Immunoprecipitation analyses confirmed activation of the miR-21 upstream-transcription factor AP-1 by Ang II. Recombinant OPN directly activated miR-21, enhanced fibrosis, and activated the phosphoinositide 3-kinase pathway. Locked nucleic acid-mediated miR-21 silencing ameliorated cardiac fibrosis development in vivo.
Conclusion: In cardiac fibrosis related to Ang II, miR-21 is transcriptionally activated and targets PTEN/SMAD7 resulting in increased fibroblast survival. OPN KO animals are protected from miR-21 increase and fibrosis development due to impaired AP-1 activation and fibroblast activation.
Circulating MicroRNAs Related to Arterial Stiffness in Adults with HIV Infection.
Nanoudis S, Yavropoulou M, Tsachouridou O, Pikilidou M, Pilalas D, Kotsa K Viruses. 2025; 16(12.
PMID: 39772253 PMC: 11680088. DOI: 10.3390/v16121945.
Ailanthone ameliorates pulmonary fibrosis by suppressing JUN-dependent MEOX1 activation.
Zhao L, Zhu Y, Tao H, Chen X, Yin F, Zhang Y Acta Pharm Sin B. 2024; 14(8):3543-3560.
PMID: 39220862 PMC: 11365432. DOI: 10.1016/j.apsb.2024.04.013.
Expression of Osteopontin and Gremlin 1 Proteins in Cardiomyocytes in Ischemic Heart Failure.
Kupryte M, Lesauskaite V, Sirataviciute V, Utkiene L, Jusiene L, Pangonyte D Int J Mol Sci. 2024; 25(15).
PMID: 39125809 PMC: 11311846. DOI: 10.3390/ijms25158240.
Emerging roles of non-coding RNAs in fibroblast to myofibroblast transition and fibrotic diseases.
Xing X, Rodeo S Front Pharmacol. 2024; 15:1423045.
PMID: 39114349 PMC: 11303237. DOI: 10.3389/fphar.2024.1423045.
Tsota M, Giardoglou P, Mentsiou-Nikolaou E, Symianakis P, Kalafati I, Kyriazopoulou-Korovesi A Noncoding RNA. 2024; 10(3).
PMID: 38921830 PMC: 11207086. DOI: 10.3390/ncrna10030033.